Velabs Therapeutics
- Steffen Runz
Steffen Runz
Director Target Discovery at Velabs Therapeutics
Steffen Runz has a background in Biology with a Diploma from Heidelberg University and completed their Dissertation at DKFZ German Cancer Research Center. Steffen has held various roles in antibody development and target discovery at companies such as VERAXA Biotech GmbH, Velabs Therapeutics GmbH, and MorphoSys AG. Their most recent roles include Director of Target Discovery and Head of Antibody Development.
Org chart
Timeline
Director Target Discovery
April 1, 2024 - present
Head Of Antibody Development
May, 2021
